These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2655436)
1. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition. Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436 [TBL] [Abstract][Full Text] [Related]
2. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man. Uttenthal LO; Ukponmwan OO; Ghiglione M; Bloom SR Dig Dis Sci; 1987 Feb; 32(2):139-44. PubMed ID: 3542445 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421). Krause HP; Keup U; Puls W Digestion; 1982; 23(4):232-8. PubMed ID: 6754513 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas. Uttenthal LO; Ukponmwan OO; Wood SM; Ghiglione M; Ghatei MA; Trayner IM; Bloom SR Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158 [TBL] [Abstract][Full Text] [Related]
5. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition. Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707 [TBL] [Abstract][Full Text] [Related]
6. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method. Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657 [TBL] [Abstract][Full Text] [Related]
7. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo. Madariaga H; Lee PC; Heitlinger LA; Lebenthal E Dig Dis Sci; 1988 Aug; 33(8):1020-4. PubMed ID: 3292164 [TBL] [Abstract][Full Text] [Related]
8. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548 [TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Qualmann C; Nauck MA; Holst JJ; Orskov C; Creutzfeldt W Scand J Gastroenterol; 1995 Sep; 30(9):892-6. PubMed ID: 8578189 [TBL] [Abstract][Full Text] [Related]
10. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123 [TBL] [Abstract][Full Text] [Related]
11. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study. Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363 [TBL] [Abstract][Full Text] [Related]
12. Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose. Gerard J; Jandrain B; Pirnay F; Pallikarakis N; Krzentowski G; Lacroix M; Mosora F; Luyckx AS; Lefèbvre PJ Diabetes; 1986 Nov; 35(11):1294-301. PubMed ID: 3530858 [TBL] [Abstract][Full Text] [Related]
13. alpha-Glucosidase inhibition in obesity. William-Olsson T Acta Med Scand Suppl; 1985; 706():1-39. PubMed ID: 3914827 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of differential disaccharide excretion in urine for non-invasive investigation of altered intestinal disaccharidase activity caused by alpha-glucosidase inhibition, primary hypolactasia, and coeliac disease. Bjarnason I; Batt R; Catt S; Macpherson A; Maxton D; Menzies IS Gut; 1996 Sep; 39(3):374-81. PubMed ID: 8949640 [TBL] [Abstract][Full Text] [Related]
15. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats. Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR Digestion; 1985; 32(2):124-7. PubMed ID: 3899816 [TBL] [Abstract][Full Text] [Related]
16. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal. O'Dea K; Turton J Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones. Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444 [TBL] [Abstract][Full Text] [Related]
18. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus. Santeusanio F; Compagnucci P Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053 [TBL] [Abstract][Full Text] [Related]
19. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Fölsch UR; Ebert R; Creutzfeldt W Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156 [TBL] [Abstract][Full Text] [Related]
20. Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose. Lembcke B; Fölsch UR; Caspary WF; Ebert R; Creutzfeldt W Digestion; 1982; 25(3):186-93. PubMed ID: 7160549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]